Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CELC
Celcuity Inc. Common Stock
stock NASDAQ

At Close
Aug 3, 2026 3:59:55 PM EDT
87.85USD+1.702%(+1.47)557,283
74.87Bid   99.70Ask   24.83Spread
Pre-market
Aug 3, 2026 9:28:30 AM EDT
86.06USD-0.370%(-0.32)541
After-hours
Aug 3, 2026 4:45:30 PM EDT
87.72USD-0.148%(-0.13)102,572
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 18, 2022
07:39AM EST  Celcuity Receives FDA Fast Track Designation For Gedatolisib In HR+ / HER2- Metastatic Breast Cancer And Provides Corporate Update   Benzinga
Nov 15, 2021
11:11AM EST  Celcuity Announces Clinical Trial Collaboration And Supply Agreement With Pfizer To Provide Ibrance(R) For Planned Phase 3 Clinical Trial   Benzinga
Nov 9, 2021
11:08AM EST  UPDATE: Celcuity Q3 Adj. EPS $(0.35) Misses $(0.31) Estimate   Benzinga
11:02AM EST  Celcuity Q3 EPS $(0.41) Misses $(0.31) Estimate   Benzinga
Nov 8, 2021
05:06AM EST  Earnings Scheduled For November 8, 2021   Benzinga
Oct 19, 2021
08:23AM EDT  The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio   Benzinga
Oct 18, 2021
04:11PM EDT  Celcuity Announces Clinical Trial Collaboration With University Of Rochester Wilmot Cancer Center And Puma Biotechnology To Conduct Phase 2 Trial Of NERLYNX Plus XELODA   Benzinga
Oct 8, 2021
11:52AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 8, 2021   Benzinga
07:06AM EDT  Canaccord Genuity Initiates Coverage On Celcuity with Buy Rating, Announces Price Target of $50   Benzinga
Sep 7, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021   Benzinga
07:44AM EDT  Jefferies Initiates Coverage On Celcuity with Buy Rating, Announces Price Target of $48   Benzinga
Aug 9, 2021
04:06PM EDT  Celcuity Q2 EPS $(0.66) Down From $(0.17) YoY   Benzinga
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
04:11AM EDT  Earnings Scheduled For August 9, 2021   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 29, 2021
10:39AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2021   Benzinga
08:07AM EDT  Cowen & Co. Initiates Coverage On Celcuity with Outperform Rating   Benzinga
Jul 27, 2021
01:18PM EDT  UPDATE: Needham On Celcuity Buy Initiation Earlier: Firm Sees Gedatolisib As Potential First-In-Class PI3K/mTOR Pathway Inhibitor Given 60% Objective Response Rate From Ongoing Phase 1B Trial; Notes Co. 'Could Broaden & Transform Targeted Cancer Therapy'   Benzinga
01:18PM EDT  UPDATE: Needham On Celcuity Buy Initiation Earlier: Firm Highlights Development Of CELsignia Next-Gen Cancer Diagnostic Discovery Platform; Uses Whole Cells To Query Entire Pathways To Give A More Comprehensive Picture Of Cancer Cell Dysfunction   Benzinga
11:13AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2021   Benzinga
11:13AM EDT  Needham Initiates Coverage On Celcuity with Buy Rating, Announces Price Target of $50   Benzinga
Jun 29, 2021
10:16AM EDT  Shares of clinical-stage biotechnology company Celcuity Inc. (CELC) are down more than 18% Tuesday morning.   RTTNews
Jun 28, 2021
04:02PM EDT  Celcuity Announces Launch Of Follow-on Offering; Size Not Disclosed   Benzinga
Jun 25, 2021
07:32AM EDT  The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs   Benzinga
May 28, 2021
08:02AM EDT  The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq   Benzinga
May 10, 2021
04:10PM EDT  Celcuity Q1 EPS $(0.25) Misses $(0.20) Estimate   Benzinga
04:09AM EDT  Earnings Scheduled For May 10, 2021   Benzinga
May 5, 2021
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
Apr 29, 2021
08:15AM EDT  The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx   Benzinga
Apr 28, 2021
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
Apr 27, 2021
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
Apr 14, 2021
07:51AM EDT  The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead   Benzinga
Apr 13, 2021
08:16AM EDT  The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug   Benzinga
Apr 12, 2021
04:01PM EDT  Celcuity Highlights PResentation Of Results From Gedatolisib Studies At AACR Annual Meeting   Benzinga
03:26PM EDT  What's Happening With ATNF Stock And CELC Stock?   Benzinga
Apr 9, 2021
02:36PM EDT  Mid-Afternoon Market Update: Dow Surges Over 100 Points; Provention Bio Shares Plunge   Benzinga
12:13PM EDT  Mid-Day Market Update: WD-40 Drops After Weak Q2 Results; Celcuity Shares Jump   Benzinga
10:38AM EDT  Mid-Morning Market Update: Markets Open Higher; US Producer Prices Rise 1% In March   Benzinga
09:22AM EDT  What's Going On With CELC Stock And PRVB Stock Today?   Benzinga
06:37AM EDT  Celcuity Stock Moves Higher After Licensing Pact With Pfizer For Gedatolisib In Breast Cancer   Benzinga
Apr 8, 2021
04:08PM EDT  Celcuity Shares To Resume Trade At 4:35 p.m. EDT   Benzinga
04:08PM EDT  Celcuity Shares Expected To Resume At 4:35 p.m. EDT   Benzinga
04:07PM EDT  UPDATE: Celcuity Says 53 Of 88 Evaluable Patients Had An Objective Response; Says Gedatolisib Showed A 'Potentially Differentiated Safety And Tolerability Profile'   Benzinga
04:06PM EDT  Celcuity Reports Preliminary Data From Phase 1b Trial Of Gedatolisib Plus Ibrance And Endocrine Therapy For Patients With ER+/HER2- Metastatic Breast Cancer   Benzinga
04:05PM EDT  Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance(r) and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update   Business Wire
04:02PM EDT  Celcuity Announces Worldwide Licensing Agreement With Pfizer To Develop, Commercialize Gedatolisib, A First-In-Class PI3K/mTOR Inhibitor For Breast Cancer   Benzinga
04:01PM EDT  Celcuity Shares Halted On Code News Pending   Benzinga
Mar 23, 2021
04:53PM EDT  Celcuity S-3 Shows Registration For $100M Mixed Securities Shelf Offering   Benzinga
Mar 17, 2021
09:28AM EDT  Celcuity Teams Up With MD Anderson, Novartis, Puma Biotech To Study New Drug Regimen In Breast Cancer   Benzinga
07:43AM EDT  The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes   Benzinga
Mar 16, 2021
07:11PM EDT  Shares of Celcuity Inc. (CELC) gained 10% in after-hours trading Tuesday. The company announced breast cancer clinical trial collaboration with MD Anderson, Novartis, and Puma Biotechnology to study new drug regimen.   RTTNews
04:01PM EDT  Celcuity Announces Breast Cancer Clinical Trial Collaboration With MD Anderson, Novertis, Puma Biotechnology To Study New Drug Regimen   Benzinga
04:00PM EDT  Celcuity Announces Breast Cancer Clinical Trial Collaboration with MD Anderson, Novartis, and Puma Biotechnology to Study New Drug Regimen   Business Wire
Feb 24, 2021
02:02PM EST  Celcuity Raises $24M Via Upsized Equity Offering At 11% Discount   Benzinga
07:46AM EST  Celcuity Prices 1.714M Share Common Stock Offering At $14/Share   Benzinga
Feb 23, 2021
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
Feb 22, 2021
08:04AM EST  Celcuity Announces $20M Proposed Public Offering Of Common Stock   Benzinga
Feb 17, 2021
06:52AM EST  HC Wainwright & Co. Maintains Buy on Celcuity, Raises Price Target to $19   Benzinga
Feb 16, 2021
04:01PM EST  Celcuity Q4 EPS $(0.21) Beats $(0.22) Estimate   Benzinga
06:49AM EST  Earnings Scheduled For February 16, 2021   Benzinga
Feb 11, 2021
11:21AM EST  Stocks That Hit 52-Week Highs On Thursday   Benzinga
Feb 10, 2021
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Jan 28, 2021
08:03AM EST  The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO   Benzinga
Jan 27, 2021
05:40PM EST  Celcuity Announces Clinical Trial Collaboration With Sarah Cannon Research Institute   RTTNews
05:36PM EST  Celcuity Announces Breast Cancer Clinical Trial Collaboration with Sarah Cannon and Pfizer to Study New Drug Regimen   Benzinga
Jan 21, 2021
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 19, 2021
02:33PM EST  Celcuity to Present at the B. Riley Oncology Investor Conference   Business Wire
Jan 14, 2021
07:57AM EST  The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates   Benzinga
Dec 24, 2020
09:26AM EST  Biggest Price Target Changes For Thursday   Benzinga
06:18AM EST  HC Wainwright & Co. Reiterates Buy on Celcuity, Raises Price Target to $14   Benzinga
Dec 23, 2020
07:07AM EST  Celcuity Reports Clinical Trial Collaboration With Massachusetts General Hospital, Puma Biotech To Conduct Phase 2 Trial   Benzinga
Nov 9, 2020
04:19PM EST  Celcuity Q3 EPS $(0.20) Beats $(0.23) Estimate   Benzinga
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Aug 10, 2020
04:32PM EDT  Celcuity Q2 EPS $(0.17) Beats $(0.18) Estimate   Benzinga
04:10AM EDT  Earnings Scheduled For August 10, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC